Cargando…

Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer’s disease spectrum

Background: Narrative discourse (ND) refers to one’s ability to verbally reproduce a sequence of temporally and logically-linked events. Impairments in ND may occur in subjects with Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease (AD), but correlates across this function, neuroimag...

Descripción completa

Detalles Bibliográficos
Autores principales: Drummond, Claudia, Coutinho, Gabriel, Monteiro, Marina Carneiro, Assuncao, Naima, Teldeschi, Alina, de Souza, Andrea Silveira, Oliveira, Natalia, Bramati, Ivanei, Sudo, Felipe Kenji, Vanderboght, Bart, Brandao, Carlos Otavio, Fonseca, Rochele Paz, de Oliveira-Souza, Ricardo, Moll, Jorge, Mattos, Paulo, Tovar-Moll, Fernanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834410/
https://www.ncbi.nlm.nih.gov/pubmed/31682234
http://dx.doi.org/10.18632/aging.102391
_version_ 1783466482627248128
author Drummond, Claudia
Coutinho, Gabriel
Monteiro, Marina Carneiro
Assuncao, Naima
Teldeschi, Alina
de Souza, Andrea Silveira
Oliveira, Natalia
Bramati, Ivanei
Sudo, Felipe Kenji
Vanderboght, Bart
Brandao, Carlos Otavio
Fonseca, Rochele Paz
de Oliveira-Souza, Ricardo
Moll, Jorge
Mattos, Paulo
Tovar-Moll, Fernanda
author_facet Drummond, Claudia
Coutinho, Gabriel
Monteiro, Marina Carneiro
Assuncao, Naima
Teldeschi, Alina
de Souza, Andrea Silveira
Oliveira, Natalia
Bramati, Ivanei
Sudo, Felipe Kenji
Vanderboght, Bart
Brandao, Carlos Otavio
Fonseca, Rochele Paz
de Oliveira-Souza, Ricardo
Moll, Jorge
Mattos, Paulo
Tovar-Moll, Fernanda
author_sort Drummond, Claudia
collection PubMed
description Background: Narrative discourse (ND) refers to one’s ability to verbally reproduce a sequence of temporally and logically-linked events. Impairments in ND may occur in subjects with Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease (AD), but correlates across this function, neuroimaging and cerebrospinal fluid (CSF) AD biomarkers remain understudied. Objectives: We sought to measure correlates among ND, Diffusion Tensor Imaging (DTI) indexes and AD CSF biomarkers in patients within the AD spectrum. Results: Groups differed in narrative production (NProd) and comprehension. aMCI and AD presented poorer inference abilities than controls. AD subjects were more impaired than controls and aMCI regarding WB (p<0.01). ROIs DTI assessment distinguished the three groups. Mean Diffusivity (MD) in the uncinate, bilateral parahippocampal cingulate and left inferior occipitofrontal fasciculi negatively correlated with NProd. Changes in specific tracts correlated with T-tau/Aβ1-42 ratio in CSF. Conclusions: AD and aMCI patients presented more ND impairments than controls. Those findings were associated with changes in ventral language-associated and in the inferior parahippocampal pathways. The latest were correlated with biomarkers’ levels in the CSF. Methods: AD (N=14), aMCI (N=31) and Control (N=39) groups were compared for whole brain (WB) and regions of interest (ROI) DTI parameters, ND and AD CSF biomarkers.
format Online
Article
Text
id pubmed-6834410
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-68344102019-11-13 Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer’s disease spectrum Drummond, Claudia Coutinho, Gabriel Monteiro, Marina Carneiro Assuncao, Naima Teldeschi, Alina de Souza, Andrea Silveira Oliveira, Natalia Bramati, Ivanei Sudo, Felipe Kenji Vanderboght, Bart Brandao, Carlos Otavio Fonseca, Rochele Paz de Oliveira-Souza, Ricardo Moll, Jorge Mattos, Paulo Tovar-Moll, Fernanda Aging (Albany NY) Research Paper Background: Narrative discourse (ND) refers to one’s ability to verbally reproduce a sequence of temporally and logically-linked events. Impairments in ND may occur in subjects with Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease (AD), but correlates across this function, neuroimaging and cerebrospinal fluid (CSF) AD biomarkers remain understudied. Objectives: We sought to measure correlates among ND, Diffusion Tensor Imaging (DTI) indexes and AD CSF biomarkers in patients within the AD spectrum. Results: Groups differed in narrative production (NProd) and comprehension. aMCI and AD presented poorer inference abilities than controls. AD subjects were more impaired than controls and aMCI regarding WB (p<0.01). ROIs DTI assessment distinguished the three groups. Mean Diffusivity (MD) in the uncinate, bilateral parahippocampal cingulate and left inferior occipitofrontal fasciculi negatively correlated with NProd. Changes in specific tracts correlated with T-tau/Aβ1-42 ratio in CSF. Conclusions: AD and aMCI patients presented more ND impairments than controls. Those findings were associated with changes in ventral language-associated and in the inferior parahippocampal pathways. The latest were correlated with biomarkers’ levels in the CSF. Methods: AD (N=14), aMCI (N=31) and Control (N=39) groups were compared for whole brain (WB) and regions of interest (ROI) DTI parameters, ND and AD CSF biomarkers. Impact Journals 2019-10-31 /pmc/articles/PMC6834410/ /pubmed/31682234 http://dx.doi.org/10.18632/aging.102391 Text en Copyright © 2019 Drummond et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Drummond, Claudia
Coutinho, Gabriel
Monteiro, Marina Carneiro
Assuncao, Naima
Teldeschi, Alina
de Souza, Andrea Silveira
Oliveira, Natalia
Bramati, Ivanei
Sudo, Felipe Kenji
Vanderboght, Bart
Brandao, Carlos Otavio
Fonseca, Rochele Paz
de Oliveira-Souza, Ricardo
Moll, Jorge
Mattos, Paulo
Tovar-Moll, Fernanda
Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer’s disease spectrum
title Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer’s disease spectrum
title_full Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer’s disease spectrum
title_fullStr Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer’s disease spectrum
title_full_unstemmed Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer’s disease spectrum
title_short Narrative impairment, white matter damage and CSF biomarkers in the Alzheimer’s disease spectrum
title_sort narrative impairment, white matter damage and csf biomarkers in the alzheimer’s disease spectrum
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834410/
https://www.ncbi.nlm.nih.gov/pubmed/31682234
http://dx.doi.org/10.18632/aging.102391
work_keys_str_mv AT drummondclaudia narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT coutinhogabriel narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT monteiromarinacarneiro narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT assuncaonaima narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT teldeschialina narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT desouzaandreasilveira narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT oliveiranatalia narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT bramatiivanei narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT sudofelipekenji narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT vanderboghtbart narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT brandaocarlosotavio narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT fonsecarochelepaz narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT deoliveirasouzaricardo narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT molljorge narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT mattospaulo narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum
AT tovarmollfernanda narrativeimpairmentwhitematterdamageandcsfbiomarkersinthealzheimersdiseasespectrum